Noticias de AGEN_US

Noticias del mercado

Últimas noticias sobre AGEN_US — 156 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: AGEN_US ✕ 156 resultados
17/04/2026 AGEN_US — Investing.com
Agenus reports trial data for cancer drug combination therapy By Investing.com
17/04/2026 AGEN_US — GuruFocus
Agenus (AGEN) Presents Promising Trial Results for Advanced Canc
17/04/2026 AGEN_US — GuruFocus
Agenus (AGEN) Presents Promising Trial Results for Advanced Canc
17/04/2026 AGEN_US — Investing.com
Agenus reports trial data for cancer drug combination therapy By Investing.com
17/04/2026 AGEN_US — Investing.com
Agenus reports trial data for cancer drug combination therapy By Investing.com
17/04/2026 AGEN_US — Stock Titan
Agenus cancer drug combo kept 43% alive at 18 months in study
17/04/2026 AGEN_US — Investing.com
Agenus reports trial data for cancer drug combination therapy
15/04/2026 AGEN_US — MarketScreener
Agenus : Corporate Overview
14/04/2026 AGEN_US — Yahoo Finance
Agenus (AGEN) is a Great Momentum Stock: Should You Buy?
14/04/2026 AGEN_US — TradingView
ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study
13/04/2026 AGEN_US — MSN
Agenus (AGEN) price target increased by 25.68% to 15.81
13/04/2026 AGEN_US — Stock Titan
Director Harrison of AGENUS INC (AGEN) granted 9,228 shares as board fees
11/04/2026 AGEN_US — MSN ES ← EN
El precio objetivo de Agenus (AGEN) aumentó un 25,68% a 15,81
09/04/2026 AGEN_US — MSN
Agenus (AGEN) price target increased by 25.68% to 15.81
06/04/2026 AGEN_US — Stock Titan
Armen of Agenus (NASDAQ: AGEN) takes salary in stock
03/04/2026 AGEN_US — The National Law Review
Agenus Announces Data from Phase II Study of BOT+BAL in Combinati
03/04/2026 AGEN_US — Yahoo Finance
Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026
03/04/2026 AGEN_US — Yahoo Finance
Can Agenus (AGEN) Run Higher on Rising Earnings Estimates?
03/04/2026 AGEN_US — Yahoo Finance
All You Need to Know About Agenus (AGEN) Rating Upgrade to Strong Buy
03/04/2026 AGEN_US — news.google.com
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer

Página 5 de 8

keyboard_arrow_up